张小丰2018-11-28 22:49
$Loxo Oncology(LOXO)$ 今天被Loxo刷屏。。主要是很多人被标题党。这个靶向药针对一种罕见的基因突变。大致占比1%。然后在这1%中效果非常惊人。也就是一个罕见药。
很多人说今天是抗癌巨大的突破,实际上突破在1年半前的ASCO医疗峰会就知道了,那时候公布了非常强大的数据,基本上已经确定这药...查看全文
旭日待东升2018-11-28 17:27
今天编辑的是我的第一条帖子,随便说说自己近日的感想。最近美国大盘,尤其是生物医药行业可谓是波澜壮阔。整个生物医药板块在周一下降了2.4%。有抗癌药Vitrakvi(又名Larotrectinib)被Approve了,但是股价却一泻千里的$Loxo Oncology(LOXO)$ 。也有由于GI.1实验数据不佳,推迟了Clinic trail而股...查看全文
e大海航行靠舵手2018-11-28 14:05
#生物制药#
LOXO Oncology 是家很神奇的公司
$Loxo Oncology(LOXO)$
这是其官网:网页链接
药物管线:
刚刚获FDA批准的广谱Trk抑制剂larotrectinib (LOXO-101),用于NTRK突变的肿瘤患者。其实以组织命名癌症已经不太合适了,基因突变的方式更加精准。
999875ass2018-11-27 16:00
FDA OKs Loxo's Vitrakvi!
小分子化合物药物还大有可为!
还记得上一篇《来看看怎么像那位老爷子一样在中国治肺癌??》中提到的LOXO各种吊炸天的小分子抗癌候选药物吗?就在今天,FDA批准了LOXO-101上市!
先来看看FDA的原文
The ...查看全文
$Loxo Oncology(LOXO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-20-003307 Act: 34 Size: 10 KB 网页链接
$Loxo Oncology(LOXO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-20-000048 Act: 34 Size: 32 KB 网页链接
$Loxo Oncology(LOXO)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2019-02-25 AccNo: 0001193125-19-049296 Size: 10 KB 网页链接
$Loxo Oncology(LOXO)$ EFFECT - Notice of Effectiveness Filed: 2019-02-21 AccNo: 9999999995-19-000306 Size: 1 KB 网页链接
$Loxo Oncology(LOXO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-02-15 AccNo: 0000950142-19-000290 Size: 146 KB 网页链接
$Loxo Oncology(LOXO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-02-15 AccNo: 0001193125-19-042490 Size: 18 KB 网页链接
$Loxo Oncology(LOXO)$ POSASR - Post-effective Amendment to an automatic shelf registration statement Filed: 2019-02-15 AccNo: 0001193125-19-042498 Size: 18 KB 网页链接
$Loxo Oncology(LOXO)$ 8-K - Current report Filed: 2019-02-15 AccNo: 0001193125-19-042505 Size: 114 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem...
$Loxo Oncology(LOXO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-15 AccNo: 0001193125-19-042509 Size: 26 KB 网页链接
$Loxo Oncology(LOXO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-15 AccNo: 0001193125-19-042519 Size: 26 KB 网页链接